Transaction · 0001104659-26-001477

Giraudo Bryan

Giraudo Bryan, DIR, reported a transaction classified as grant at Protagonist Therapeutics, Inc involving 3762.000000 shares for an estimated $0.00. Reported holdings after the transaction were 3762.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
PTGXProtagonist Therapeutics, Inc
Filing timeJan 07
Trade dateJan 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$82.34
Pre-filing
1mo ago +4.5%1w ago +7.8%1d ago +6.1%
Returns since
7d +3.5%30d +2.6%90d +26.0%180d +59.7%1y +87.9%

PTGX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PTGX since 2026-01-07Filed 240 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001104659-26-001477
Stock Option (right to buy)
Transaction date
Jan 02, 2026
Filed Jan 07, 2026, 12:41 AM · 5d delay
Shares
3.76k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
3.76k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vest…

  2. F2

    The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Original filing · 0001104659-26-001477
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PTGX